Clinical Trials Logo

Clinical Trial Summary

Polycystic kidney disease (PKD) is a genetic disease that occurs in 1 in 500 individuals and leads to kidney failure in half of all affected. Currently, no treatments exist for PKD. PKD-affected kidney cells divide and multiply inappropriately, and form fluid-filled sacs called cysts. Kidney cysts continue to grow throughout life, destroying normal kidney tissue, leading to kidney failure. Based on evidence from basic science research it is believed that drinking high amounts of water can slow the abnormal cysts growth. This study aims to look at changes in urine composition with high water intake in PKD-affected persons compared to healthy individuals.


Clinical Trial Description

n/a


Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science


Related Conditions & MeSH terms


NCT number NCT00784030
Study type Interventional
Source New York University School of Medicine
Contact
Status Active, not recruiting
Phase N/A
Start date November 2008
Completion date November 2009

See also
  Status Clinical Trial Phase
Completed NCT00571909 - Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study N/A
Recruiting NCT00890279 - Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) Phase 2
Unknown status NCT00541853 - CCB Safety Study in Treatment of Hypertension of ADPKD Phase 4
Not yet recruiting NCT00067977 - Clinical Trial to Slow the Progression of ADPKD N/A